In CRC cells harbouring mutations in C4b-binding protein alpha chain (C4BPA), this complement-associated protein is retained in the cytoplasm in response to the chemotherapy agent oxaliplatin [11]. The gene discussed is C4BPA; the disease is colorectal carcinoma.